Prab at 19:12, 16 March 2025

2025-03-16T19:12:02Z

← Older revision		Revision as of 19:12, 16 March 2025
Line 28:		Line 28:

	{{medicine-stub}}		{{medicine-stub}}
	~~{{No image}}~~
	<gallery>		<gallery>
	File:Bretylium.svg\|Bretylium chemical structure		File:Bretylium.svg\|Bretylium chemical structure
	File:Bretylium_3D_BS.png\|3D model of Bretylium		File:Bretylium_3D_BS.png\|3D model of Bretylium
	</gallery>		</gallery>

Prab: CSV import

2025-02-17T02:06:54Z

CSV import

← Older revision		Revision as of 02:06, 17 February 2025
Line 29:		Line 29:
	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
			<gallery>
			File:Bretylium.svg\|Bretylium chemical structure
			File:Bretylium_3D_BS.png\|3D model of Bretylium
			</gallery>

Prab: CSV import

2025-02-10T08:14:46Z

CSV import

← Older revision		Revision as of 08:14, 10 February 2025
Line 28:		Line 28:

	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-03-10T20:45:49Z

CSV import

New page

'''Bretylium''' is a [[drug]] that was primarily used as an [[antiarrhythmic agent]] to treat [[ventricular fibrillation]] and [[ventricular tachycardia]]. It is a class III antiarrhythmic drug, which means it works by blocking [[potassium channels]] and thus prolonging the action potential duration and refractory period.

== Mechanism of Action ==

Bretylium works by blocking the release of [[norepinephrine]] from the [[sympathetic nervous system]]'s nerve endings. This action can help to stabilize the heart rhythm and prevent the occurrence of life-threatening [[arrhythmias]]. It also has a direct action on the heart muscle cells (myocytes), where it blocks potassium channels, leading to a prolongation of the action potential duration and refractory period.

== Uses ==

Bretylium was primarily used to treat life-threatening ventricular arrhythmias, such as ventricular fibrillation and ventricular tachycardia. However, it is no longer commonly used due to the availability of more effective and safer alternatives.

== Side Effects ==

The most common side effects of bretylium include [[nausea]], [[vomiting]], [[hypotension]] (low blood pressure), and [[dyspnea]] (difficulty breathing). In rare cases, it can cause more serious side effects such as [[pulmonary edema]] (fluid accumulation in the lungs) and [[hypertension]] (high blood pressure).

== History ==

Bretylium was first synthesized in the 1950s and was initially used as an antihypertensive agent. However, it was later found to be effective in treating ventricular arrhythmias and was widely used for this purpose until the 1990s, when newer and safer drugs became available.

== See Also ==

* [[Antiarrhythmic agent]]
* [[Ventricular fibrillation]]
* [[Ventricular tachycardia]]

[[Category:Drugs]]
[[Category:Antiarrhythmic agents]]
[[Category:Potassium channel blockers]]

{{medicine-stub}}

Bretylium - Revision history

Prab at 19:12, 16 March 2025

Prab: CSV import

Prab: CSV import

Prab: CSV import